Charles Schwab’s Tenaya Therapeutics TNYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-130,192
Closed -$74.2K 3576
2025
Q1
$74.2K Sell
130,192
-22,396
-15% -$12.8K ﹤0.01% 3372
2024
Q4
$218K Hold
152,588
﹤0.01% 3316
2024
Q3
$294K Hold
152,588
﹤0.01% 3287
2024
Q2
$473K Buy
152,588
+24,468
+19% +$75.9K ﹤0.01% 3220
2024
Q1
$670K Buy
128,120
+8,588
+7% +$44.9K ﹤0.01% 2916
2023
Q4
$387K Hold
119,532
﹤0.01% 3161
2023
Q3
$305K Hold
119,532
﹤0.01% 3208
2023
Q2
$702K Buy
119,532
+6,499
+6% +$38.1K ﹤0.01% 2900
2023
Q1
$322K Buy
113,033
+51,632
+84% +$147K ﹤0.01% 3070
2022
Q4
$123K Sell
61,401
-4,937
-7% -$9.92K ﹤0.01% 3238
2022
Q3
$193K Hold
66,338
﹤0.01% 3167
2022
Q2
$374K Sell
66,338
-2,366
-3% -$13.3K ﹤0.01% 3155
2022
Q1
$810K Buy
68,704
+33,161
+93% +$391K ﹤0.01% 2932
2021
Q4
$674K Buy
35,543
+1,332
+4% +$25.3K ﹤0.01% 3052
2021
Q3
$707K Buy
+34,211
New +$707K ﹤0.01% 3017